Gurevičienė, G. 2020. PD-L1 INHIBITOR ATEZOLIZUMAB▼ - FOR NSCLC TREATMENT AFTER PRIOR CHEMOTHERAPY. Pulmonology and allergology. 3, 1 (Sep. 2020), 102-108. DOI:https://doi.org/10.37499/PIA.154.